Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04214093
What this trial is testing

AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaMultiple Myeloma+1 more
AstraZeneca 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04130516
What this trial is testing

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

Who this might be right for
Solid Tumor, Adult
Linnaeus Therapeutics, Inc. 200
Early research (Phase 1)Looking for participantsNCT07050459
What this trial is testing

A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 220
Testing effectiveness (Phase 2)Study completedNCT04720976
What this trial is testing

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorNSCLC
Allist Pharmaceuticals, Inc. 58
Not applicableUnknownNCT01533779
What this trial is testing

Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity

Who this might be right for
Pediatric Solid MalignanciesPediatric Hematological Malignancies
Tel-Aviv Sourasky Medical Center 50
Early research (Phase 1)Not Yet RecruitingNCT06872580
What this trial is testing

QLS1209 in theTreatment of Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 149
Early research (Phase 1)UnknownNCT05125523
What this trial is testing

Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 264
Early research (Phase 1)Study completedNCT04045496
What this trial is testing

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Jacobio Pharmaceuticals Co., Ltd. 40
Early research (Phase 1)Looking for participantsNCT06840886
What this trial is testing

PHST001 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancerEndometrial Cancer+2 more
Pheast Therapeutics 272
Testing effectiveness (Phase 2)WithdrawnNCT00627627
What this trial is testing

Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
MedImmune LLC 56
Early research (Phase 1)Study completedNCT03934359
What this trial is testing

Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai De Novo Pharmatech Co., Ltd. 19
Early research (Phase 1)Looking for participantsNCT06655246
What this trial is testing

Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)Gastrointestinal Stromal CancerGastrointestinal Stromal Neoplasm+2 more
Kura Oncology, Inc. 157
Early research (Phase 1)Study completedNCT02660034
What this trial is testing

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumors
BeiGene 229
Testing effectiveness (Phase 2)Study completedNCT06179511
What this trial is testing

Study of AZD9829 in CD123+ Hematological Malignancies

Who this might be right for
Hematological Malignancies
AstraZeneca 56
Early research (Phase 1)WithdrawnNCT01452334
What this trial is testing

Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy

Who this might be right for
Non-Hodgkin's LymphomaHodgkin LymphomaMultiple Myeloma+1 more
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT06685718
What this trial is testing

A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung CancerNSCLC+3 more
BeOne Medicines 33
Testing effectiveness (Phase 2)Looking for participantsNCT05532696
What this trial is testing

Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerHER2 Mutations
Anbogen Therapeutics, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT04394624
What this trial is testing

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sanofi 31
Testing effectiveness (Phase 2)Looking for participantsNCT06028074
What this trial is testing

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Georgiamune Inc 111
Testing effectiveness (Phase 2)Looking for participantsNCT07751042
What this trial is testing

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Who this might be right for
Advanced Solid Tumor
Strand Therapeutics Inc. 220
Next Page